BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9058140)

  • 21. Preoperative chemotherapy followed by esophagectomy compared with surgery alone in the treatment of squamous cell carcinoma of the esophagus.
    Hernández Lizoain JL; Cienfuegos JA; Pardo F; Martínez Regueira F; Sola I; Aristu J; Azinovic I
    Rev Esp Enferm Dig; 1998 Apr; 90(4):275-90. PubMed ID: 9623271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologic prognostic factors in esophageal squamous cell carcinoma: a follow-up study of 74 patients with or without preoperative chemoradiation therapy.
    Torres CM; Wang HH; Turner JR; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
    Mod Pathol; 1999 Oct; 12(10):961-8. PubMed ID: 10530561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy.
    Kim MK; Kim SB; Ahn JH; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HY; Shin JH; Cho KJ; Ryu JS; Park SI
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):725-34. PubMed ID: 18164836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.
    Brücher BL; Becker K; Lordick F; Fink U; Sarbia M; Stein H; Busch R; Zimmermann F; Molls M; Höfler H; Siewert JR
    Cancer; 2006 May; 106(10):2119-27. PubMed ID: 16607651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
    Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
    Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C; Taillier G; Van Seuningen I; Triboulet JP
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.
    Fujita H; Sueyoshi S; Yamana H; Shinozaki K; Toh U; Tanaka Y; Mine T; Kubota M; Shirouzu K; Toyonaga A; Harada H; Ban S; Watanabe M; Toda Y; Tabuchi E; Hayabuchi N; Inutsuka H
    World J Surg; 2001 Apr; 25(4):424-31. PubMed ID: 11344392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.
    Chao YK; Chan SC; Chang HK; Liu YH; Wu YC; Hsieh MJ; Tseng CK; Liu HP
    Eur J Surg Oncol; 2009 Mar; 35(3):289-94. PubMed ID: 18396384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
    Lin FC; Durkin AE; Ferguson MK
    Ann Thorac Surg; 2004 Nov; 78(5):1783-9. PubMed ID: 15511475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
    Ancona E; Ruol A; Santi S; Merigliano S; Sileni VC; Koussis H; Zaninotto G; Bonavina L; Peracchia A
    Cancer; 2001 Jun; 91(11):2165-74. PubMed ID: 11391598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.
    Javeri H; Arora R; Correa AM; Hofstetter WL; Lee JH; Liao Z; McAleer MF; Maru D; Bhutani MS; Swisher SG; Izzo JG; Ajani JA
    Cancer; 2008 Sep; 113(6):1302-8. PubMed ID: 18623381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.
    Tachimori Y; Kanamori N; Uemura N; Hokamura N; Igaki H; Kato H
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):49-54. PubMed ID: 19154902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of hyperthermia combined with chemotherapy and irradiation for the treatment of patients with carcinoma of the esophagus.
    Sugimachi K; Matsuda H; Ohno S; Fukuda A; Matsuoka H; Mori M; Kuwano H
    Surg Gynecol Obstet; 1988 Oct; 167(4):319-23. PubMed ID: 3420507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.
    Tachibana M; Tabara H; Kotoh T; Kinugasa S; Dhar DK; Hishikawa Y; Masunaga R; Kubota H; Nagasue N
    Am J Gastroenterol; 1999 Mar; 94(3):757-65. PubMed ID: 10086663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of the second cycle response to cisplatin-based chemotherapy as preoperative treatment for esophageal squamous cell carcinoma.
    Akita H; Doki Y; Miyata H; Hirao T; Yano M; Takachi K; Miyashiro I; Sasaki Y; Ishikawa O; Ohigashi H; Imaoka S
    J Surg Oncol; 2006 Apr; 93(5):401-9. PubMed ID: 16550577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.